AI (r)evolution -- where are we heading? Thoughts about the future of music and sound technologies in the era of deep learning

Artificial Intelligence (AI) technologies such as deep learning are evolving very quickly bringing many changes to our everyday lives. To explore the future impact and potential of AI in the field of music and sound technologies a doctoral day was held between Queen Mary University of London (QMUL, UK) and Sciences et Technologies de la Musique et du Son (STMS, France). Prompt questions about current trends in AI and music were generated by academics from QMUL and STMS. Students from the two institutions then debated these questions. This report presents a summary of the student debates on the topics of: Data, Impact, and the Environment; Responsible Innovation and Creative Practice; Creativity and Bias; and From Tools to the Singularity. The students represent the future generation of AI and music researchers. The academics represent the incumbent establishment. The student debates reported here capture visions, dreams, concerns, uncertainties, and contentious issues for the future of AI and music as the establishment is rightfully challenged by the next generation

A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)

Meeting abstrac

Adrenalectomy for solid tumor metastases: Results of a multicenter European study

Background. We assessed the results of adienalectomy for solid tumor metastases in 317 patients recruited from 30 European Centers. Methods. Patients with histologically proven adrenal metastatic disease and undergoing complete removal(s) of the affected.gland(s) were eligible. Results. Non-small cell lung cancer (NSCLC) was the most frequent tumor type followed by colorectal and renal cell carcinoma. Adrenal metastases were synchronous 6 months) in 73 (23%) patients and isolated in 213 (67%). The median disease-free interval was 18.5 months. Laparoscopic resection was used in 46% of patients. Surgery was limited to the adrenal gland in 73% of patients and RO resection was achieved in 86% of cases. The median overall survival was 29 months (95 % confidence interval,. 24.69733.30). The survival rates at 1, 2, 3, and 5 years were 80%, 61%,. 42%, and 35%, respectively. Patients with renal" cancer showed a median survival of 84 months, patients with NSCLC 26 months, and patients with colorectal cancer 29 months (P =.017). Differences in survival between metachronous and synchronous lesions were also significant (30 vs 23 months; P =.038). Conclusion. Surgical removal of adrenal metastasis is associated with long-term survival in se

Adrenalectomy for solid tumor metastases: Results of a multicenter European study

BACKGROUND: We assessed the results of adrenalectomy for solid tumor metastases in 317 patients recruited from 30 European centers. METHODS: Patients with histologically proven adrenal metastatic disease and undergoing complete removal(s) of the affected gland(s) were eligible. RESULTS: Non-small cell lung cancer (NSCLC) was the most frequent tumor type followed by colorectal and renal cell carcinoma. Adrenal metastases were synchronous (???6 months) in 73 (23%) patients and isolated in 213 (67%). The median disease-free interval was 18.5 months. Laparoscopic resection was used in 46% of patients. Surgery was limited to the adrenal gland in 73% of patients and R0 resection was achieved in 86% of cases. The median overall survival was 29 months (95% confidence interval, 24.69-33.30). The survival rates at 1, 2, 3, and 5 years were 80%, 61%, 42%, and 35%, respectively. Patients with renal cancer showed a median survival of 84 months, patients with NSCLC 26 months, and patients with colorectal cancer 29 months (P = .017). Differences in survival between metachronous and synchronous lesions were also significant (30 vs. 23 months; P = .038). CONCLUSION: Surgical removal of adrenal metastasis is associated with long-term survival in selected patient